| Filings | Filing Date | Form Type | Company | Description | AI | Link |
|---|---|---|---|---|---|---|
| Filings | Description | AI | Link | |||
|---|---|---|---|---|---|---|
 BMNRBITMINE IMMERSION TECHNOLOGIES, INC. 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:45 AM ET | 8-K | BMNR BITMINE IMMERSION TECHNOLOGIES, INC. | 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 Bitmine Immersion Technologies (NYSE: BMNR) announced its ETH holdings reached 6,070,092 tokens as of November 8, 2026, equal to 4.97% of the total ETH supply, with total crypto, c… | ||
 FTHFaeth Therapeutics, Inc. 8.01Other events9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:45 AM ET | 8-K | FTH Faeth Therapeutics, Inc. | 8.01Other events9.01ExhibitsExhibits:EX-99.1 Faeth Therapeutics reported topline Phase 2 data for PIKTOR (serabelisib plus sapanisertib) combined with paclitaxel in heavily pretreated advanced endometrial cancer, achieving a… | ||
 ICCMIceCure Medical Ltd. Exhibits:EX-99.1 | Nov 9, 20268:45 AM ET | 6-K | ICCM IceCure Medical Ltd. | Exhibits:EX-99.1 | ||
 IIPRINNOVATIVE INDUSTRIAL PROPERTIES INC 8.01Other events9.01ExhibitsExhibits:EX-1.1EX-5.1+1 | Nov 9, 20268:39 AM ET | 8-K | IIPR INNOVATIVE INDUSTRIAL PROPERTIES INC | 8.01Other events9.01ExhibitsExhibits:EX-1.1EX-5.1+1 Innovative Industrial Properties amended its equity distribution agreements with six sales agents to add its 9.25% Series B Preferred Stock to its at-the-market offering program, a… | ||
 SSNCSS&C Technologies Holdings Inc 1.01Material agreement2.03Direct financial obligation3.02Unregistered sale+2Exhibits:EX-10.1EX-10.2+4 | Nov 9, 20268:39 AM ET | 8-K | SSNC SS&C Technologies Holdings Inc | 1.01Material agreement2.03Direct financial obligation3.02Unregistered sale+2Exhibits:EX-10.1EX-10.2+4 | ||
 SONSONOCO PRODUCTS CO 5.02Officer/director change7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:38 AM ET | 8-K | SON SONOCO PRODUCTS CO | 5.02Officer/director change7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | ||
 FRVOFervo Energy Co 2.02Results of operationsExhibits:EX-99.1 | Nov 9, 20268:37 AM ET | 8-K | FRVO Fervo Energy Co | 2.02Results of operationsExhibits:EX-99.1 | ||
 APVOAptevo Therapeutics Inc. 8.01Other events9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:35 AM ET | 8-K | APVO Aptevo Therapeutics Inc. | 8.01Other events9.01ExhibitsExhibits:EX-99.1 Aptevo Therapeutics announced it presented new preclinical data at the SITC 2026 Annual Meeting on November 7, 2026, showing its next-generation multispecific molecules can drive t… | ||
 LOGCContextLogic Holdings Inc. 2.02Results of operations7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:35 AM ET | 8-K | LOGC ContextLogic Holdings Inc. | 2.02Results of operations7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | ||
 NWLNEWELL BRANDS INC. 5.02Officer/director change9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:35 AM ET | 8-K | NWL NEWELL BRANDS INC. | 5.02Officer/director change9.01ExhibitsExhibits:EX-99.1 | ||
 VTGNVistagen Therapeutics, Inc. 8.01Other events9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:34 AM ET | 8-K | VTGN Vistagen Therapeutics, Inc. | 8.01Other events9.01ExhibitsExhibits:EX-99.1 Vistagen (Nasdaq: VTGN) announced constructive feedback from a recent FDA Type C meeting on the registrational path for fasedienol, its lead intranasal candidate for social anxiety… | ||
 VIRVir Biotechnology, Inc. 7.01Reg FD8.01Other events9.01Exhibits | Nov 9, 20268:31 AM ET | 8-K | VIR Vir Biotechnology, Inc. | 7.01Reg FD8.01Other events9.01Exhibits Vir Biotechnology reported that its pivotal Phase 3 ECLIPSE 1 trial of monthly subcutaneous elebsiran plus tobevibart met its primary endpoint in chronic hepatitis delta, with 44%… | ||
 JDZGJIADE Ltd Exhibits:EX-99.1EX-99.2 | Nov 9, 20268:30 AM ET | 6-K | JDZG JIADE Ltd | Exhibits:EX-99.1EX-99.2 | ||
 ALARAlarum Technologies Ltd. Exhibits:EX-99.1EX-99.2+2 | Nov 9, 20268:30 AM ET | 6-K | ALAR Alarum Technologies Ltd. | Exhibits:EX-99.1EX-99.2+2 | ||
 EMPDEmpery Digital Inc. 7.01Reg FD8.01Other events9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:30 AM ET | 8-K | EMPD Empery Digital Inc. | 7.01Reg FD8.01Other events9.01ExhibitsExhibits:EX-99.1 Empery Digital repurchased 155,040 shares in the week ended November 6, 2026 at an average price of $2.36 per share under its $200 million buyback program, bringing cumulative repu… | ||
 BDRXBiodexa Pharmaceuticals Plc Exhibits:EX-99.1 | Nov 9, 20268:30 AM ET | 6-K | BDRX Biodexa Pharmaceuticals Plc | Exhibits:EX-99.1 | ||
 ONMDOneMedNet Corp 2.02Results of operations9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20268:30 AM ET | 8-K | ONMD OneMedNet Corp | 2.02Results of operations9.01ExhibitsExhibits:EX-99.1 | ||
 CISSC3is Inc. Exhibits:EX-4.1EX-4.2 | Nov 9, 20268:30 AM ET | 6-K | CISS C3is Inc. | Exhibits:EX-4.1EX-4.2 | ||
 BBCIBradbury Capital Inc. Exhibits:EX-10.1EX-10.2+1 | Nov 9, 20268:28 AM ET | 6-K | BBCI Bradbury Capital Inc. | Exhibits:EX-10.1EX-10.2+1 | ||
 ECECOPETROL S.A. Exhibits:EX-99.1 | Nov 9, 20268:27 AM ET | 6-K | EC ECOPETROL S.A. | Exhibits:EX-99.1 |
Searching Signal8’s SEC filing archive — filings from Oct 2021 onward.
1-20 of 10,000+ filings